BMO Capital Markets Reiterates Underperform Rating, $30 PT on Zoetis on Avian Flu Scare
April 05, 2013 at 13:26 PM EDT
In a report published Friday, BMO Capital Markets analyst Alex Arfaei reiterated an Underperform rating and $30.00 price target on Zoetis (NYSE: ZTS ). In the report, Arfaei noted, “Shares of Zoetis are weak today in part related to the 14 human cases of the H7N9 virus, an unusual strain
